METHODS OF TREATING DISEASES AND DISORDERS WITH DEUPIRFENIDONE
Disclosed herein are methods of treating a fibrotic-mediated disorder or a collagen-mediated disorder, that include administering to a subject in need thereof a high dose of deupirfenidone, e.g., a total daily dose of up to 2500 mg. Also disclosed are interventional dosing for functionally impairing diseases and dosing for chronic disease.
1 . A method of treating a life-threatening fibrotic disorder, comprising administering to a subject in need thereof a total daily dose of up to 2500 mg, of deuterium-enriched pirfenidone having the structure:
wherein the life-threatening fibrotic disorder is treated in the subject.
2 - 8 . (canceled)
9 . A method of treating a functionally impairing fibrotic-mediated disorder or a collagen-mediated disorder, comprising administering to a subject in need thereof:
an interventional total daily dose of up to 2500 mg of deuterium-enriched pirfenidone having the structure:
.
10 - 17 . (canceled)
18 . A method of treating a chronic fibrotic-mediated disorder or a collagen-mediated disorder, the method comprising administering to a subject in need thereof a 1000 mg or 1500 mg total daily dose of deupirfenidone from induction.
19 - 21 . (canceled)
22 . A method of treating a fibrotic-or collagen-mediated disorder, comprising administering to a subject in need thereof a total daily dose of up to 2500 mg of deuterium-enriched pirfenidone having the structure:
wherein the fibrotic-or collagen-mediated disorder is treated in the subject.
23 - 54 . (canceled)